These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 8483621)
41. Pertussis seroprevalence in emergency department staff. Wright SW; Edwards KM; Decker MD; Lamberth MM Ann Emerg Med; 1994 Sep; 24(3):413-7. PubMed ID: 8080138 [TBL] [Abstract][Full Text] [Related]
42. Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population. Knuf M; Zepp F; Meyer C; Grzegowski E; Wolter J; Riffelmann M; Wirsing von König CH Vaccine; 2006 Mar; 24(12):2043-8. PubMed ID: 16356597 [TBL] [Abstract][Full Text] [Related]
44. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey. Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581 [TBL] [Abstract][Full Text] [Related]
45. IgG responses after booster vaccination with different pertussis vaccines in Dutch children 4 years of age: effect of vaccine antigen content. Hendrikx LH; Berbers GA; Veenhoven RH; Sanders EA; Buisman AM Vaccine; 2009 Nov; 27(47):6530-6. PubMed ID: 19729085 [TBL] [Abstract][Full Text] [Related]
46. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age. Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640 [TBL] [Abstract][Full Text] [Related]
47. Influence of maternal vaccination against diphtheria, tetanus, and pertussis on the avidity of infant antibody responses to a pertussis containing vaccine in Belgium. Caboré RN; Maertens K; Dobly A; Leuridan E; Van Damme P; Huygen K Virulence; 2017 Oct; 8(7):1245-1254. PubMed ID: 28277900 [TBL] [Abstract][Full Text] [Related]
48. [Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough]. Chodorowska M Med Dosw Mikrobiol; 1999; 51(3-4):269-80. PubMed ID: 10803256 [TBL] [Abstract][Full Text] [Related]
49. An outbreak of whooping cough in a highly vaccinated urban community. Strebel P; Hussey G; Metcalf C; Smith D; Hanslo D; Simpson J J Trop Pediatr; 1991 Mar; 37(2):71-6. PubMed ID: 2027168 [TBL] [Abstract][Full Text] [Related]
50. Seroprevalence study of B. pertussis infection in health care workers in Catalonia, Spain. Urbiztondo L; Broner S; Costa J; Rocamora L; Bayas JM; Campins M; Esteve M; Borras E; Domínguez A; For The Study Of The Immune Status In Health Care TW Hum Vaccin Immunother; 2015; 11(1):293-7. PubMed ID: 25483549 [TBL] [Abstract][Full Text] [Related]
51. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry]. Matter HC; Schmidt-Schläpfer G; Zimmermann H Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704 [TBL] [Abstract][Full Text] [Related]
52. How to make sense of pertussis immunogenicity data. Olin P; Hallander HO; Gustafsson L; Reizenstein E; Storsaeter J Clin Infect Dis; 2001 Dec; 33 Suppl 4():S288-91. PubMed ID: 11709761 [TBL] [Abstract][Full Text] [Related]
53. Development of improved vaccines against whooping cough: current status. Marzouqi I; Richmond P; Fry S; Wetherall J; Mukkur T Hum Vaccin; 2010 Jul; 6(7):543-53. PubMed ID: 20448470 [TBL] [Abstract][Full Text] [Related]
54. A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis. Progetto Pertosse Working Group. Greco D; Salmaso S; Mastrantonio P; Giuliano M; Tozzi AE; Anemona A; Ciofi degli Atti ML; Giammanco A; Panei P; Blackwelder WC; Klein DL; Wassilak SG N Engl J Med; 1996 Feb; 334(6):341-8. PubMed ID: 8538704 [TBL] [Abstract][Full Text] [Related]
55. Different IgG-subclass distributions after whole-cell and acellular pertussis infant primary vaccinations in healthy and pertussis infected children. Hendrikx LH; Schure RM; Oztürk K; de Rond LG; de Greeff SC; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Sep; 29(40):6874-80. PubMed ID: 21803088 [TBL] [Abstract][Full Text] [Related]
56. [Problems of whooping cough not yet solved. Epidemiology and vaccination strategy in Germany--country-wide field study]. Schneeweiss B; Swidsinski S Fortschr Med; 1997 Aug; 115(24):28-30. PubMed ID: 9410816 [No Abstract] [Full Text] [Related]
57. Identifying long-term memory B-cells in vaccinated children despite waning antibody levels specific for Bordetella pertussis proteins. Hendrikx LH; Oztürk K; de Rond LG; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Feb; 29(7):1431-7. PubMed ID: 21187178 [TBL] [Abstract][Full Text] [Related]
58. Pertussis and the Minnesota State Fair: Demonstrating a Novel Setting for Efficiently Conducting Seroepidemiologic Studies. Sanstead E; Basta NE; Martin K; Cruz V; Ehresmann K; Kulasingam S J Community Health; 2018 Oct; 43(5):937-943. PubMed ID: 29627911 [TBL] [Abstract][Full Text] [Related]
59. Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Storsaeter J; Hallander H; Farrington CP; Olin P; Möllby R; Miller E Vaccine; 1990 Oct; 8(5):457-61. PubMed ID: 2251872 [TBL] [Abstract][Full Text] [Related]
60. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Cherry JD; Gornbein J; Heininger U; Stehr K Vaccine; 1998 Dec; 16(20):1901-6. PubMed ID: 9796041 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]